EPS Bio Technology Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 112.66 million compared to TWD 88.48 million a year ago. Revenue was TWD 112.66 million compared to TWD 88.48 million a year ago. Net income was TWD 2.51 million compared to net loss of TWD 5.35 million a year ago. Basic earnings per share from continuing operations was TWD 0.11 compared to basic loss per share from continuing operations of TWD 0.22 a year ago. Diluted earnings per share from continuing operations was TWD 0.11 compared to diluted loss per share from continuing operations of TWD 0.22 a year ago.